Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Similar articles for PubMed (Select 12707737)

1.

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting.

Reubi JC, Waser B.

Eur J Nucl Med Mol Imaging. 2003 May;30(5):781-93. Epub 2003 Apr 18. Review.

PMID:
12707737
2.

Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting.

Reubi C, Gugger M, Waser B.

Eur J Nucl Med Mol Imaging. 2002 Jul;29(7):855-62. Epub 2002 Apr 20.

PMID:
12111125
3.

Diagnostic applications of radiolabeled peptides in nuclear endocrinology.

Behr TM, Béhé M, Becker W.

Q J Nucl Med. 1999 Sep;43(3):268-80. Review.

PMID:
10568142
5.

Peptide receptor expression in GEP-NET.

Reubi JC.

Virchows Arch. 2007 Aug;451 Suppl 1:S47-50. Epub 2007 Aug 8. Review.

PMID:
17684767
6.

Somatostatin and other Peptide receptors as tools for tumor diagnosis and treatment.

Reubi JC.

Neuroendocrinology. 2004;80 Suppl 1:51-6. Review.

PMID:
15477718
7.

Imaging tumors with peptide-based radioligands.

Behr TM, Gotthardt M, Barth A, Béhé M.

Q J Nucl Med. 2001 Jun;45(2):189-200. Review.

PMID:
11476170
8.
9.
10.

Old and new peptide receptor targets in cancer: future directions.

Reubi JC.

Recent Results Cancer Res. 2013;194:567-76. doi: 10.1007/978-3-642-27994-2_34.

PMID:
22918784
11.

High expression of peptide receptors as a novel target in gastrointestinal stromal tumours.

Reubi JC, Körner M, Waser B, Mazzucchelli L, Guillou L.

Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):803-10. Epub 2004 Feb 18.

PMID:
14985869
12.

Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours.

de Herder WW, Hofland LJ, van der Lely AJ, Lamberts SW.

Endocr Relat Cancer. 2003 Dec;10(4):451-8. Review.

13.

Regulatory peptide receptors in human hepatocellular carcinomas.

Reubi JC, Zimmermann A, Jonas S, Waser B, Neuhaus P, Läderach U, Wiedenmann B.

Gut. 1999 Nov;45(5):766-74.

14.

GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting.

Körner M, Stöckli M, Waser B, Reubi JC.

J Nucl Med. 2007 May;48(5):736-43.

15.

Tumor imaging and therapy using radiolabeled somatostatin analogues.

de Jong M, Breeman WA, Kwekkeboom DJ, Valkema R, Krenning EP.

Acc Chem Res. 2009 Jul 21;42(7):873-80. doi: 10.1021/ar800188e.

PMID:
19445476
16.

Investigation of cancer cell lines for peptide receptor-targeted drug development.

Sun L, Luo J, Mackey LV, Morris LM, Franko-Tobin LG, LePage KT, Coy DH.

J Drug Target. 2011 Sep;19(8):719-30. doi: 10.3109/1061186X.2011.558089.

PMID:
21830941
17.

Expression of receptors for gut peptides in pancreata of BOP-treated and control hamsters.

Tang C, Biemond I, Appel MJ, Visser CJ, Woutersen RA, Lamers CB.

Carcinogenesis. 1996 Oct;17(10):2171-5.

18.

Current status and perspectives in peptide receptor radiation therapy.

Ansquer C, Kraeber-Bodéré F, Chatal JF.

Curr Pharm Des. 2009;15(21):2453-62. Review.

PMID:
19601842
19.

Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors.

Waser B, Rehmann R, Sanchez C, Fourmy D, Reubi JC.

J Clin Endocrinol Metab. 2012 Feb;97(2):482-8. doi: 10.1210/jc.2011-2454. Epub 2011 Nov 23.

PMID:
22112810
20.

Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA.

Waser B, Eltschinger V, Linder K, Nunn A, Reubi JC.

Eur J Nucl Med Mol Imaging. 2007 Jan;34(1):95-100. Epub 2006 Aug 15.

PMID:
16909223
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk